abobo your post is rude and shows no respect. It's a joke to...

abobo your post is rude and shows no respect. It's a joke to start such a post with "due respect". I've struggled through your vitriol all the while doubting an emotional, rude, truth distorting individual had much to teach me. There are many flavours of cash flow. At no point am I confused between cash flow or P&Ls.

Unlike me you say? I say thank god for that. I would never ever want to be like you. I prefer to intelligently analyse and discuss not spew emotional distortions.

I thought we had identified the operating, investing and financing cash flows, and still came up $10M short. My time will be better spent checking the balance sheet to see where any cash flow swings may have come from. If you've got a better idea please let me know.

For your reference the common cash flows are cash flow from operations (CFFO), owner earnings, FCF to the firm, free cash flow to equity, unfettered free cash flow, the very basic change in cash and equivalents and net cash flow.

Anyway I emailed the company and look forward to a polite reply. Which is something you may wish to try from time to time.

Of course biotech is risky. Buying a good pipeline for free is as low risk as it gets in biotech. abobo states Cook is atrocious and then only point to one change in share price at one company as your evidence. Not quite a body of evidence is it. abobo if you have any substantial analysis please share it. I'm keen to learn and happy to be proved wrong in my assumption that you'd be unable to do so.

I'd suggest calling someone a LIAR over a few possible cents which could easily be explained by timing etc is a rather extreme call, which says more about abobo than Peter Cook.

abobo you get what you give, no respect! Though I do hold a hand out if you want to pull yourself out of your funk and in to a intelligent polite conversation.